Dobutamine stress echocardiography in the evaluation of the coronary patient;L'échocardiographie de stress sous dobutamine pour l'évaluation du patient coronarien

Medecine et Hygiene

Volumn 59, Issue 2337, 2001, Pages 548-550

  Ciaroni, Stefano ^a  

^a LA TOUR HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DIPYRIDAMOLE; DOBUTAMINE; THALLIUM 201;

CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; EXERCISE ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE PERFORMANCE; HEART MUSCLE ISCHEMIA; HUMAN; INTERMETHOD COMPARISON; NON INVASIVE MEASUREMENT; RELIABILITY; SAFETY; SHORT SURVEY; STRESS ECHOCARDIOGRAPHY; TOMOGRAPHY;

EID: 0343774051     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (14)

1. Ciaroni S. L'échocardiographie de stress sous dobutamine, une nouvelle méthode d'investigation de la maladie coronarienne. Revue Médicale de la Suisse Romande 1998; 118: 609-16.
2. Santoro GM, Sciagrà R, Buonamici P, et al. Head-to-head comparison of exercise stress testing, pharmacologic stress echocardiography, and perfusion tomography as first-line examination for chest pain in patients without history of coronary artery disease. J Nucl Cardiol 1998; 5: 19-27.
3. Mairesse GH, Marwick TH, Vanoverschelde JJ, et al. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with two-dimensional echocardiography and technetium-99m methoxyl isobutyl isonitrile (MIBI) perfusion scintigraphy. J Am Coll Cardiol 1994; 24: 920-7.
4. Ciaroni S, Bloch A, Albrecht L, et al. Diagnosis of coronary artery disease in patients with permanent cardiac pacemaker by dobutamine stress echocardiography or exercise thallium-201 myocardial tomography. Echocardiography 2000; 17: 675-9.
5. Akosah KO, Mohanty PK. Role of dobutamine stress echocardiography in heart transplant patients. Chest 1998; 113: 809-15.
6. Song J-K, ParK S-W, Kang D-H, et al. Safety and clinical impact of ergonovine stress echocardiography for diagnosis of coronary vasospasm. J Am Coll Cardiol 2000; 35: 1850-6.
7. Geleiynse ML, Elnnedy A, van Domburg RT, et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? Circulation 1997; 96: 137-47.
8. Senior R, Soman P, Khattar RS, et al. Prognostic value of dobutamine stress echocardiography in patients undergoing diagnostic coronary arteriography. Am J Cardiol 1997; 79: 1610-4.
9. Poldermans D, Fioretti PM, Boersma E, et al. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience. Circulation 1999; 99: 757-62.
10. Ciaroni S, Bloch A, Vanautryve B, et al. Valeur pronostique de l'échocardiographie à la dobutamine chez les patients âgés suspects de maladie coronarienne avec un électrocardiogramme de repos anormal. Médecine Cardiovasculaire 2000; 3 (Suppl.2): 16S (Abstract).
11. Davila-Roman VG, Waggoner AD, Sicard CA, et al. Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol 1993; 21: 957-63.
12. Poldermans D, Amese M, Fioretti PM, et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol 1995; 26: 648-53.
13. Vanoverschelde JL, D'Hondt AM, Marwick T, et al. Head-to-head comparison of exercise-redistribution-reinjection thallium single photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996; 28: 432-42.
14. Picano E, Sicari R, Landi P, et al. The prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: A dobutamine stress echocardiography study. Circulation 1998; 98: 1078-94.